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adverse events. Main Results: The number of CD34+ cells in the 
leukapheresis products were similar in the two groups: the geo- 
metric mean number of CD34+ cells was 1.73 x 10^6/kg in the 
once-daily group and 2.08 x 10^6/kg in the divided-dose group 
(P=.0.37). The geometric mean number of TNCs in the products 
was 6.43 x 10^8/kg in the once-daily group and 6.35 x 10A8/kg in 
the twice-daily group (P=0.87). Although the median total doses 
of analgesic drug were similar in both groups (6.35mg/kg vs 
7.69mg/kg acetoaminophen, P=0.79), the donors in the once-dally 
group experienced significantly less pain than twice-daily group 
(median AUS of VAS; 21.5 vs 52.5 ram*days, P=0.043). The inci- 
dences and severities of adverse vents other than pain were simi- 
lar in both groups. Conclusions: In comparison with two-divided 
dose regimen, once daily injection of 400btg/m^2 of G-CSF is 
equally effective for allogeneic PBSC nmbilization and associated 
with less pain. Taldng into account of donor's convenience, once- 
daily regimen is preferable to twice-daily regimen. 
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IN VITRO PRIMING AND EXPANSION OF CMV-SPECIFIC THI AND 
TCI T CELLS FROM NAIVE CORD BLOOD LYMPHOCYTES BY AUTOL- 
OGOUS DENDRITIC CELLS 
S:abolcs, P., Ma1~i, L.; Reese, 3/14 I~;rtzbe'rg, ft.; Par~e, K. Dulee Uni- 
versity, Pediatric BMT Progr, zm, Dm'taam, NC. 
BACKGROUND: Adoptive transfer of CMV specific cytoto~c T 
cells (CTL) expanded in vitro from donor memory cells have reduced 
CMV disease in the allogeneic BMT setting. However, dais approach 
has not been feasible in the unrelated cord blood transplant (uUCBT) 
setting as cord blood contains naive, unprimed T ceils. YVe developed 
an in vitro protocol to prime and expand CMV-specific CTL from 
cord blood. METHODS: Monocytes from 6 UCB units were cul- 
tured with GM-CSF/IL-4 for 6 days to generate immature Des 
(Mo/DCs). Autologous UCB lymphocytes were primed either with 
CMV-lysate-pulsed Mo/DCs (CMV+) or as negative controls 
unpulsed (CNIV-) or sham Iysate loaded Mo/DCs. Prior to priming 
CMV +/- loaded immature DC received 12h maturation signals 
(TNFc~+PGE2) inducing expression of CDS0, CD86 and HLA mol- 
ecules. For restimulation and expansion of CTL cultures DC were 
generated from CD34+ cells cultured in SCF/Flt-3L/GM-CSF/IL- 
4 for 14 ~ 21days and GM-CSF/IL-4 for 6days. DCs and responder 
lymphocytes were cultured in the presence of low dose IL-2 
(10IU/ml), IL-7, and IL-12 to skew the priming and expansion 
towards ThI and Tcl cells. CTL cultures were -stimulated weeldy 
for 5~ 7 weeks. After the 4th week CD3+ T cells were tested weeHy 
by ic FACS analysis for CMV-specific IFNy, TNFc( secretion. 
CMV-specific cytotoxicity was tested by LDH release assay on 
CMV+, CMV or sham lysate loaded autologous Mo/DC. 
RESULTS: CMV+ cultures expanded significantly more (3.5 ~ 13.39 
tbld) than CMV- cultures (0.65 ~ 7.8 fold) despite identical cytokine 
milieu. There was a preferential expansion of CD45RA-/RO+ 'mem- 
ory' T cells in CMV+ cultures compared to CMV- cultures (CMV+: 
66~86% of CD3+ versus CMV-: 30 ~ 46% of CD3+. CMV-specific 
interferon gamma produchag T cells were 4.7 ~ 35.3 % (mean: 16.1%) 
in CMV+ cultures and 0 ~ 2% (mean 0.5%) of CD3+ in CMV-cul 
rares respectively (p=0.025) witla bo h CD4+ (Thl) and CD8+ (TcI) 
T cells contributing. CMV-specific CTtOto.-dcity at10:1 E:T ratio was 
31 ~ 48 % from CMV+ cultures and 10~ 13% from CMV- or sham 
lysate cultures. CONCLUSION: This dataset is the first to our 
knowledge to demonstrate the generation of CMV-specific CTLs 
that were primed and expanded in vitro from naive umbilical cord 
lymphocytes. This approach may lead to effective clinical strategies 
against CMV infection in the uUCB transplantation setting. 
175 
UPREGULATION OF THE EXPRESSION OF MOLECULES INVOLVED IN 
ALLORECOGNITION: IMPLICATIONS FOR POTENTIATING THE MIXED 
LYMPHOCYTE REACTION PRIOR TO SELECTIVE ALLOREACTIVE T 
CELL DEPLETION 
Davies, ff.K.; Koh, M.B.; Prentice, H.; Lowdell, 3/I.FV. Depa;~tment of 
Haematology, Royal Free Hospital, London, United Kingdom. 
Various mechanisms ofselective depletion of alloreactive T cells in 
haematopoietic stem ceil (HSC)grafts have been described: all 
depend upon the stimulation of donor alloreactive cells byrecipient 
cells in a unidirectional mixed lymphocyte reaction (MLR). In the 
HLA identical donor setting, stimulation of alloreactive donor cells in 
a standard MLR often fails to occur: in this setting amodification of 
the MLR with cytoldne pre-treatment of stimulator cells has been 
described. We investigated the effect of two strategies designed to 
potentiate the MLR on expression of cell surface molecules impor- 
tant in allostimulation. The expression of adhesion molecules 
(CD1 la, CD54(ICAM I)), co-stimulatury molecules (CD80 and 
CD86) and HLA class I and Class II molecules were measured by 
flow cytometry after stimulation of monocytes and T cells with 
TNF-alpha, IL4 and/or gamma-interferon f r 24 and 48 hours. Sim- 
ilar observations were made of T cells stinmlated with immobilized 
nfitogenic OKT3 +/- agonistic anti-CD28. The e~pression of CD178 
(Fas ligand) in these cells was also determined at 24 and 48 hours. 
Effective upregulation of molecules involved in allorecognition 
occurred with all three cytokines on monocytes and with g-IFN and 
TNF a on T cells. Use of immobilised OKT3 caused much greater 
increases in eNaression of similar molecules on T ceils and an increase 
in the proportion of T ceils expressing FAS ligand. The addition of 
anti-CD28 to OKT3 had no additional benefit in upregulation of 
these molecules. Results are summarised below (NT=Not Tested). 
Both strategies may enhance alloantigen presentation i  the HLA 
identical situation and facilitate the activation (and subsequent 
removal) of alloreactive cells in HSC grafts. The increase in the pro- 
portion ofT ceils expressing FAS ligand seen with OKT3 stimulation 
may enhance FAS-mediated apoptosis of alloreactive cells. We are 
currendy investigating the use of both techniques in modifications of
the MLR as part of our selective allodepletion research programme. 
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TIME-TEMPERATURE STUDY OF CELL SURVIVAL IN BONE MARROW 
(BM) AND BLOOD HEMATOPOIETIC PROGENITOR CELL (HPC) GRAFTS 
Rosenthal, H.S/; Miller, ft.:; Hicks, AI.1; Weisdo~f, D/; Waller, E.K/ 
i. Emmy University, Atlanta, GA; 2. U~iversity of Mimzesota, 3/lin- 
neapolis, 3/[~ 
Background: Standard practice in BM and blood HPC trans- 
plants facilitated by the NMDP is to ship BM HPC grafts at 
room temperature and blood HPC grafts at 4°C. There is lim- 
ited information regarding the effect of storage conditions on 
the content of cell subsets in the graft. We undertook a 
prospective study of the effect of time and temperature on the 
content of viable CD34+ cells, T-cell, B-cell, NK cells and den- 
dritic cell subsets in blood and BM HPC grafts. Method: Small 
aliquots of blood (N=4) and BM (N=5) HPC grafts from 
patients harvested at two transplant centers were obtained from 
quality control samples discarded from the processing laborato 
ries. The number of viable nucleated cells was determined by 
fluorescent microscopy following staining with ethidium bro- 
mide and acridine orange and storage for 24, 48 or 72 hours at 
4°C or RT. The content of CD34+ cells, T-cells, B-cells, NK 
cells and dendritic cell subsets was determined using flow 
cytometry and propidium iodide to electronically exclude non- 
viable cells. Results: BM grafts had better overall cell viability 
during storage than bIood HPC grafts at both temperatures. 
The median number of viable CD34+ cells in BM HPC grafts 
was stable at 4°C and RT during 48 hours storage then 
declined to 50% and 29% of the initial values, respectively, 
after 72 hours. In contrast, there was a steady decline in the 
numbers of viable CD34+ cells in blood HPC grafts throughout 
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